LOJUXTA

This brand name is authorized in Austria, Brazil, Croatia, Estonia, France, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, UK.

Active ingredients

The drug LOJUXTA contains one active pharmaceutical ingredient (API):

1	Lomitapide UNII X4S83CP54E - LOMITAPIDE MESYLATE
	Lomitapide is a selective inhibitor of microsomal transfer protein (MTP), an intracellular lipid-transfer protein that is found in the lumen of the endoplasmic reticulum and is responsible for binding and shuttling individual lipid molecules between membranes. MTP plays a key role in the assembly of apo B containing lipoproteins in the liver and intestines. Inhibition of MTP reduces lipoprotein secretion and circulating concentrations of lipoprotein-borne lipids including cholesterol and triglycerides.
	Read more about Lomitapide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LOJUXTA Hard, capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AX12		C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AX Other lipid modifying agents
Discover more medicines within C10AX12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	574421050000102, 574421050000202, 574421050000302
EE	Ravimiamet	1621707, 1621729, 1621730, 1713484, 1713495, 1713507
FR	Base de données publique des médicaments	69243759, 69565055, 69851117
GB	Medicines & Healthcare Products Regulatory Agency	234945, 234952, 234963
IL	מִשְׂרַד הַבְּרִיאוּת	8958, 8959, 8960
IT	Agenzia del Farmaco	042920013, 042920025, 042920037, 042920049, 042920052, 042920064
LT	Valstybinė vaistų kontrolės tarnyba	1071079, 1071080, 1071081, 1080464, 1080465, 1080466
NL	Z-Index G-Standaard, PRK	106984, 106992, 107018
PL	Rejestru Produktów Leczniczych	100311607, 100311613, 100311620, 100388082, 100388099, 100388107
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66217001, W66218001, W66219001